Results 241 to 250 of about 91,813 (297)

Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival-A prospective cohort study in Australia. [PDF]

open access: yesInt J Cancer
Na R   +9 more
europepmc   +1 more source

National Bleeding Disorder Foundation Clinical Practice Recommendations for Laboratory Screening of Iron Deficiency With and Without Anemia in the Inherited Bleeding Disorders Population

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction The National Bleeding Disorder Foundation (NBDF) Medical and Scientific Advisory Council (MASAC) was formed in 1954 and issues recommendations and advisories pertinent to the bleeding disorders community. MASAC is comprised of > 25 rotating members from different medical disciplines and lived experience experts.
Glaivy Batsuli   +15 more
wiley   +1 more source

[Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Shlyakhto EV   +22 more
europepmc   +1 more source

Adipose Tissue Sex Steroids in Postmenopausal Women With and Without Menopausal Hormone Therapy.

open access: yesJ Clin Endocrinol Metab
Hetemäki N   +7 more
europepmc   +1 more source

Diabetes and menopause: A critical yet neglected intersection

open access: yes
Diabetic Medicine, EarlyView.
Isabell Haage   +3 more
wiley   +1 more source

Menopausal Hormone Therapy

Journal of Obstetrics and Gynaecology Canada, 2005
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
Bhagu R, Bhavnani, Ronald C, Strickler
openaire   +3 more sources

Menopausal hormone therapy and menopausal symptoms

Fertility and Sterility, 2014
A majority of women will experience bothersome symptoms related to declining and/or fluctuating levels of estrogen during their menopausal transition. Vasomotor symptoms, vaginal dryness, poor sleep, and depressed mood have all been found to worsen during the menopausal transition.
Zain A, Al-Safi, Nanette, Santoro
openaire   +2 more sources

Home - About - Disclaimer - Privacy